Raza S M, Recinos P F, Avendano J, Adams H, Jallo G I, Quinones-Hinojosa A
The Johns Hopkins Neuro-Oncology Surgical Outcomes Research Laboratory, Department of Neurosurgery, The Johns Hopkins School of Medicine, Baltimore, Maryland 21231, USA.
Minim Invasive Neurosurg. 2011 Feb;54(1):5-11. doi: 10.1055/s-0031-1273734. Epub 2011 Apr 20.
The surgical management of deep intra-axial lesions still requires microsurgical approaches that utilize retraction of deep white matter to obtain adequate visualization. We report our experience with a new tubular retractor system, designed specifically for intracranial applications, linked with frameless neuronavigation for a cohort of intraventricular and deep intra-axial tumors.
The ViewSite Brain Access System (Vycor, Inc) was used in a series of 9 adult and pediatric patients with a variety of pathologies. Histological diagnoses either resected or biopsied with the system included: colloid cyst, DNET, papillary pineal tumor, anaplastic astrocytoma, toxoplasmosis and lymphoma. The locations of the lesions approached include: lateral ventricle, basal ganglia, pulvinar/posterior thalamus and insular cortex. Post-operative imaging was assessed to determine extent of resection and extent of white matter damage along the surgical trajectory (based on T (2)/FLAIR and diffusion restriction/ADC signal).
Satisfactory resection or biopsy was obtained in all patients. Radiographic analysis demonstrated evidence of white matter damage along the surgical trajectory in one patient. None of the patients experienced neurological deficits as a result of white matter retraction/manipulation.
Based on a retrospective review of our experience, we feel that this access system, when used in conjunction with frameless neuronavigational systems, provides adequate visualization for tumor resection while permitting the use of standard microsurgical techniques through minimally invasive craniotomies. Our initial data indicate that this system may minimize white matter injury, but further studies are necessary.
深部轴内病变的手术治疗仍需要采用显微外科手术方法,即通过牵拉深部白质来获得足够的视野。我们报告了我们使用一种专门为颅内应用设计的新型管状牵开器系统的经验,该系统与无框架神经导航系统相结合,用于一组脑室内和深部轴内肿瘤患者。
ViewSite脑通路系统(Vycor公司)应用于9例患有各种病变的成人和儿童患者。用该系统切除或活检的组织学诊断包括:胶样囊肿、胚胎发育不良性神经上皮肿瘤(DNET)、乳头状松果体瘤、间变性星形细胞瘤、弓形虫病和淋巴瘤。所处理病变的位置包括:侧脑室、基底神经节、丘脑枕/丘脑后部和岛叶皮质。术后进行影像学评估,以确定切除范围以及沿手术路径的白质损伤程度(基于T(2)/液体衰减反转恢复序列(FLAIR)和扩散受限/表观扩散系数(ADC)信号)。
所有患者均获得了满意的切除或活检结果。影像学分析显示1例患者沿手术路径有白质损伤迹象。没有患者因白质牵拉/操作而出现神经功能缺损。
基于对我们经验的回顾性分析,我们认为该通路系统与无框架神经导航系统联合使用时,可为肿瘤切除提供足够的视野,同时允许通过微创开颅手术使用标准显微外科技术。我们的初步数据表明该系统可能会将白质损伤降至最低,但仍需要进一步研究。